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Multiple drug therapy is commonly prescribed in patients with rheumatoid arthritis, 
and the list of drugs capable of inducing hepatic microsomal enzymes is growing 
rapidly. The effect of phenobarbitone 60 mg twice daily was studied in steroid 
dependent rheumatoid arthritics. Tritiated prednislone half-life were performed 
before and after phenobarbitone treatment, and patients were assessed clinically by 
standard methodology. Significant clinical deterioration was noted in the patients as 
evidenced by significant increases in articular index, pain scores and duration of 
morning stiffness. A 25% reduction in the half-life of prednislone was also found. 
Changes in disease activity following introduction of additional therapy may have an 
iatrogenic component related to changes in drug metabolism rather than being 
dismissed casually as naturally occurring relapses or remissions. 
 
